Cyclophil Me (Cyclosporine) is an immunosuppressant medicine. Doctors prescribe it to stop the body from rejecting a new kidney, liver, or heart after a transplant. It also helps in the treatment of autoimmune diseases such as psoriasis, rheumatoid arthritis, and chronic dry eye. Because it lowers the activity of the immune system, it allows the body to accept the transplanted organ and reduces harmful inflammation. For more information, you can visit Mayo Clinic, Drugs.com, FDA, WebMD, PubMed, Healthline, and the World Health Organization (WHO).
Key Benefits & Uses
-
Prevents rejection of transplanted organs like kidney, liver, and heart.
-
Controls autoimmune conditions, including rheumatoid arthritis and psoriasis.
-
Treats chronic dry eye by reducing inflammation.
-
Balances the immune system without shutting it down completely.
How to Use
Take Cyclophil Me exactly as your doctor tells you. Usually, patients take it twice daily, at the same time every day. You may take it with or without food, but remain consistent with your choice. Furthermore, your doctor may order regular blood tests to check drug levels and kidney function. Always follow these instructions to get the best results.
Important Safety Information
Use Cyclophil Me only under medical supervision. Tell your doctor if you have kidney disease, liver problems, infections, or high blood pressure. Avoid direct sunlight for long periods, because the medicine increases the risk of skin cancer. In addition, stay away from grapefruit juice, as it can interfere with how the drug works.
Common Side Effects
You may experience:
-
High blood pressure
-
Extra hair growth
-
Tremors or shaking
-
Swollen gums
-
Nausea, vomiting, or stomach upset
-
Headache and dizziness
If you notice severe infection, very little urine, or unusual bleeding, contact your doctor immediately.
Why Choose Cyclophil Me (Cyclosporine)?
Cyclophil Me offers a reliable and clinically proven cyclosporine formulation. Doctors across the world trust it to prevent organ rejection and control autoimmune diseases. Moreover, medical research from PubMed and guidelines from WHO support its safety and effectiveness. Therefore, this medicine remains a top choice for long-term treatment.

